US2022273845A1PendingUtilityA1

Nano scale decoration of scaffold-free microtissue using functionalised gold nanostructures

Assignee: UNIV ARIZONA STATEPriority: Oct 11, 2017Filed: May 9, 2022Published: Sep 1, 2022
Est. expiryOct 11, 2037(~11.2 yrs left)· nominal 20-yr term from priority
C12N 2533/10A61L 27/3873A61L 2430/20C12N 5/0656A61L 27/3895A61L 27/54C12N 5/0657A61L 27/3886A61L 27/3804A61L 27/3826C12N 5/0658A61L 27/047A61L 27/26A61L 27/22C12N 2501/165A61L 27/3604A61L 27/3821
60
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A method for regeneration or repair of an infarcted myocardium including an infarcted region in an animal comprising injecting into the animal a composition including one or more gold nanostructures is disclosed.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A method for regeneration or repair of an infarcted myocardium including an infarcted region in an animal comprising injecting into the animal a composition comprising:
 one or more gold nanostructures linked to one or more cell adhesion peptides;   a plurality of cardiac myocytes or cardiac myoblasts, wherein the cardiac myocytes or cardiac myoblasts are conjugated to the one or more gold nanostructures, wherein the plurality of cardiac myocytes or cardiac myoblasts are arranged in a cluster; and   a plurality of fibroblasts, wherein the fibroblasts are arranged in at least one layer of fibroblasts that substantially surrounds the cluster of gold-nanostructure-conjugated cardiac myocytes or gold-nanostructure-conjugated cardiac myoblasts, wherein optionally, the gold nanostructures are further linked to one or more anti-inflammatory peptides, one or more antiapoptotic peptides, one or more antinecrotic peptides, one or more antioxidant particles, one or more liposomes, one or more nanoliposomes, one or more microRNAs, or one or more siRNAs.   
     
     
         2 . The method of  claim 1 , wherein the composition is delivered via catheter to the infarcted region. 
     
     
         3 . The method of  claim 1 , wherein the composition is injected within the infarcted region. 
     
     
         4 . The method of  claim 1 , wherein the one or more gold nanostructures are additionally linked to one or more anti-inflammatory peptides. 
     
     
         5 . The method of  claim 1 , wherein the one or more gold nanostructures are wires, rods or plates. 
     
     
         6 . The method of  claim 1 , wherein the cardiac myocytes are human-induced pluripotent-stem-cell-derived cardiac myocytes. 
     
     
         7 . The method of  claim 6 , wherein the one or more gold nanostructures are additionally linked to one or more vasculogenic peptides. 
     
     
         8 . The method of  claim 7 , wherein the one or more vasculogenic peptides comprises a VEGF-mimetic peptide. 
     
     
         9 . The method of  claim 7 , wherein the one or more vasculogenic peptides comprises a VEGF-mimetic QK-peptide. 
     
     
         10 . The method of  claim 7 , wherein the one or more cell adhesion peptides are RGD peptides. 
     
     
         11 . The method of  claim 10 , wherein the one or more gold nanostructures are capped with polyethylene glycol bi-linker. 
     
     
         12 . A method for regeneration or repair of an infarcted myocardium including an infarcted region in an animal comprising injecting into the animal a composition comprising:
 one or more gold nanostructures linked to one or more cell adhesion peptides;   a plurality of cardiac myocytes or cardiac myoblasts, wherein the cardiac myocytes or cardiac myoblasts are conjugated to the one or more gold nanostructures, wherein the plurality of cardiac myocytes or cardiac myoblasts are arranged in a cluster, and   a plurality of fibroblasts, wherein the fibroblasts are arranged in at least one layer of fibroblasts that substantially surrounds the cluster of gold-nanostructure-conjugated cardiac myocytes or gold-nanostructure-conjugated cardiac myoblasts, wherein the one or more gold nanostructures are coupled to a cell-targeting moiety.   
     
     
         13 . The method of  claim 12 , wherein the composition is delivered via catheter to the infarcted region. 
     
     
         14 . The method of  claim 12 , wherein the composition is injected within the infarcted region. 
     
     
         15 . The method of  claim 12 , wherein the one or more gold nanostructures are linked to the cell-targeting moiety through a direct bond. 
     
     
         16 . The method of  claim 12 , wherein the one or more gold nanostructures are linked to the cell-targeting moiety through a linking group. 
     
     
         17 . The method of  claim 16 , wherein the targeting moiety is a RGD peptide including an amino terminus and the linking group is a divalent radical of formula —S-(PEG)-C(═O)—, wherein C(═O)— is bonded to the amino terminus and PEG is a polyethyleneoxy chain. 
     
     
         18 . The method of  claim 16 , wherein the linking group is a divalent, branched or unbranched, saturated or unsaturated, hydrocarbon chain, having from 2 to 25 carbon atoms, wherein one or more of the carbon atoms is optionally replaced by (O), and wherein the chain is optionally substituted on carbon with one or more substituents selected from (C1-C6)alkoxy, (C3-C6)cycloalkyl, (C1-C6)alkanoyl, (C1-C6)alkanoyloxy, (C1-C6)alkoxycarbonyl, (C1-C6)alkylthio, azido, cyano, nitro, halo, hydroxy, oxo (═O), carboxy, aryl, aryloxy, heteroaryl, and heteroaryloxy. 
     
     
         19 . The method of  claim 12 , wherein the cell adhesion moiety includes RGD, DGEA (SEQ ID NO: 3), GRGDSP (SEQ ID NO: 4), or GRGDY (SEQ ID NO: 5).

Join the waitlist — get patent alerts

Track US2022273845A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.